[Spin on]
[Spin off]
[Reset]
[High quality]
[Low quality]
[White background]
[Black background]
|
[Spin on]
[Spin off]
[Reset]
[High quality]
[Low quality]
[White background]
[Black background]
|
PDB | 7qju Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced Malignancies. |
Resolution | 1.8 Å |
Binding residue (original residue number in PDB) | W103 H104 S105 E107 D109 V112 Y154 S159 H160 P161 I178 R201 L246 L315 G316 D317 L318 F372 W373 Q374 L391 E392 E394 R420 |
Binding residue (residue number reindexed from 1) | W27 H28 S29 E31 D33 V36 Y78 S83 H84 P85 I102 R125 L170 L232 G233 D234 L235 F289 W290 Q291 L308 E309 E311 R337 |
|